Market Indices
Sector Heatmap
ALDX — Aldeyra Therapeutics, Inc.
NasdaqAldeyra Therapeutics, Inc.
- O
- 1.26
- H
- 1.31
- L
- 1.20
- V
- 1.16M
ALDX — Latest News & Headlines
14 StoriesAfter three FDA denial letters, Aldeyra plans a formal challenge over its dry eye drug. - Stock Titan
After three FDA denial letters, Aldeyra plans a formal challenge over its dry eye drug. Stock Titan
Aldeyra Therapeutics, Inc. (ALDX) Discusses FDRR and FDA Review Process for Reproxalap in Dry Eye Disease - Slideshow (NASDAQ:ALDX) 2026-09-30 - Seeking Alpha
Aldeyra Therapeutics, Inc. (ALDX) Discusses FDRR and FDA Review Process for Reproxalap in Dry Eye Disease - Slideshow (NASDAQ:ALDX) 2026-09-30 Seeking Alpha
ACAD Stock Down 13% as Phase II Alzheimer's Study Misses Primary Goal - tradingview.com
ACAD Stock Down 13% as Phase II Alzheimer's Study Misses Primary Goal tradingview.com
Aldeyra Therapeutics Inc. (ALDX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Aldeyra Therapeutics Inc. (ALDX) Stock Price | Live Quotes & Charts | NASDAQ timothysykes.com
What's going on in today's after hours session - ChartMill
What's going on in today's after hours session ChartMill
ALDX Reiterated by BTIG -- Price Target Maintained at $9.00 - GuruFocus
ALDX Reiterated by BTIG -- Price Target Maintained at $9.00 GuruFocus
Aldeyra Therapeutics Stock Surges as It Files an FDA Dispute Resolution - Aldeyra Therapeutics (NASDAQ:AL - benzinga.com
Aldeyra Therapeutics Stock Surges as It Files an FDA Dispute Resolution - Aldeyra Therapeutics (NASDAQ:AL benzinga.com
H.C. Wainwright reiterates Neutral on Aldeyra stock at $2 target By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Neutral on Aldeyra stock at $2 target By Investing.com Investing.com Nigeria
Acadia's Daybue Patent Allowance Extends U.S. Protection to March 2041 - The Globe and Mail
Acadia's Daybue Patent Allowance Extends U.S. Protection to March 2041 The Globe and Mail
ALDX Reiterated by HC Wainwright & Co. -- Price Target Maintained at $2.00 - GuruFocus
ALDX Reiterated by HC Wainwright & Co. -- Price Target Maintained at $2.00 GuruFocus
Zacks Investment Research - גלובס
Zacks Investment Research גלובס
Merck Inks $2.1B Deal With Chinese Biotech to Expand Oncology Pipeline - es.tradingview.com
Merck Inks $2.1B Deal With Chinese Biotech to Expand Oncology Pipeline es.tradingview.com
Novo's Sogroya Gains CHMP Nod for Idiopathic Short Stature in the EU - tradingview.com
Novo's Sogroya Gains CHMP Nod for Idiopathic Short Stature in the EU tradingview.com
Live Aldeyra Therapeutics, Inc. (ALDX) Technical Analysis - Traders Union
Live Aldeyra Therapeutics, Inc. (ALDX) Technical Analysis Traders Union